BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28804172)

  • 1. Antimicrobial resistance: from global agenda to national strategic plan, Thailand.
    Tangcharoensathien V; Sattayawutthipong W; Kanjanapimai S; Kanpravidth W; Brown R; Sommanustweechai A
    Bull World Health Organ; 2017 Aug; 95(8):599-603. PubMed ID: 28804172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thailand's national strategic plan on antimicrobial resistance: progress and challenges.
    Sumpradit N; Wongkongkathep S; Malathum K; Janejai N; Paveenkittiporn W; Yingyong T; Chuxnum T; Vijitleela A; Boonyarit P; Akaleephan C; Manosuthi W; Thienthong V; Srinha J; Wongsrichai S; Laoprasert T; Athipunyakom P; Kriengchaiyaprug N; Intarukdach K; Numsawad S; Somjetanakul N; Punnin S; Kiatying-Angsulee N
    Bull World Health Organ; 2021 Sep; 99(9):661-673. PubMed ID: 34475603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementing national strategies on antimicrobial resistance in Thailand: potential challenges and solutions.
    Sommanustweechai A; Tangcharoensathien V; Malathum K; Sumpradit N; Kiatying-Angsulee N; Janejai N; Jaroenpoj S
    Public Health; 2018 Apr; 157():142-146. PubMed ID: 29524812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of antimicrobial resistance in Cameroon: Feasibility of implementing the National Action Plan.
    Amin ET; Omeichu AA; Shu DM; Ekome SRE; Njumkeng C; van der Sande MAB
    Trop Med Int Health; 2021 Oct; 26(10):1231-1239. PubMed ID: 34218501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population knowledge and awareness of antibiotic use and antimicrobial resistance: results from national household survey 2019 and changes from 2017.
    Tangcharoensathien V; Chanvatik S; Kosiyaporn H; Kirivan S; Kaewkhankhaeng W; Thunyahan A; Lekagul A
    BMC Public Health; 2021 Nov; 21(1):2188. PubMed ID: 34844593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addressing the threat of antibiotic resistance in Thailand: monitoring population knowledge and awareness.
    Tangcharoensathien V; Sommanustweechai A; Chanvatik S; Kosiyaporn H; Tisocki K
    WHO South East Asia J Public Health; 2018 Sep; 7(2):73-78. PubMed ID: 30136664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial resistance national level dialogue and action in Ghana: setting and sustaining the agenda and outcomes.
    Koduah A; Gyansa-Lutterodt M; Hedidor GK; Sekyi-Brown R; Asiedu-Danso M; Asare BA; Ackon AA; Annan EA
    One Health Outlook; 2021 Oct; 3(1):18. PubMed ID: 34663477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial Use and Resistance in Australia (AURA) surveillance system: coordinating national data on antimicrobial use and resistance for Australia.
    Turnidge JD; Meleady KT
    Aust Health Rev; 2018 Jun; 42(3):272-276. PubMed ID: 28637576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated one-day surveillance of antimicrobial use, antimicrobial consumption, antimicrobial resistance, healthcare-associated infection, and antimicrobial resistance burden among hospitalized patients in Thailand.
    Thamlikitkul V; Rattanaumpawan P; Sirijatuphat R; Wangchinda W
    J Infect; 2020 Jul; 81(1):98-106. PubMed ID: 32360884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview of antimicrobial susceptibility patterns of gram-positive bacteria from National Antimicrobial Resistance Surveillance Thailand (NARST) program from 2000 to 2005.
    Mootsikapun P; Trakulsomboon S; Sawanpanyalert P; Aswapokee N; Suankratay C
    J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S87-90. PubMed ID: 21294504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of the South Korean national antimicrobial resistance surveillance system, Kor-GLASS, in 2016.
    Lee H; Yoon EJ; Kim D; Jeong SH; Shin JH; Shin JH; Shin KS; Kim YA; Uh Y; Park C; Lee KJ
    Euro Surveill; 2018 Oct; 23(42):. PubMed ID: 30352643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National Action Plan on Antimicrobial Resistance (AMR) 2016-2020 and relevant activities in Japan.
    Ohmagari N
    Glob Health Med; 2019 Dec; 1(2):71-77. PubMed ID: 33330758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanding beyond zoonoses: the benefits of a national One Health coordination mechanism to address antimicrobial resistance and other shared health threats at the human-animal-environment interface in Kenya.
    Kimani T; Kiambi S; Eckford S; Njuguna J; Makonnen Y; Rugalema G; Morzaria SP; Lubroth J; Fasina FO
    Rev Sci Tech; 2019 May; 38(1):155-171. PubMed ID: 31564733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Veterinary antimicrobial resistance containment in Bangladesh: Evaluating the national action plan and scoping the evidence on implementation.
    Orubu ESF; Zaman MH; Rahman MT; Wirtz VJ
    J Glob Antimicrob Resist; 2020 Jun; 21():105-115. PubMed ID: 31600599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance for control of antimicrobial resistance.
    Tacconelli E; Sifakis F; Harbarth S; Schrijver R; van Mourik M; Voss A; Sharland M; Rajendran NB; Rodríguez-Baño J;
    Lancet Infect Dis; 2018 Mar; 18(3):e99-e106. PubMed ID: 29102325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Implementation of Antimicrobial Resistance Surveillance and Antimicrobial Stewardship Programs in Tanzanian Health Facilities a Year After Launch of the National Action Plan.
    Sangeda RZ; Kibona J; Munishi C; Arabi F; Manyanga VP; Mwambete KD; Horumpende PG
    Front Public Health; 2020; 8():454. PubMed ID: 32974264
    [No Abstract]   [Full Text] [Related]  

  • 17. Implementation of the World Health Organization Global Antimicrobial Resistance Surveillance System in Uganda, 2015-2020: Mixed-Methods Study Using National Surveillance Data.
    Nabadda S; Kakooza F; Kiggundu R; Walwema R; Bazira J; Mayito J; Mugerwa I; Sekamatte M; Kambugu A; Lamorde M; Kajumbula H; Mwebasa H
    JMIR Public Health Surveill; 2021 Oct; 7(10):e29954. PubMed ID: 34673531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their use.
    Shrestha P; Cooper BS; Coast J; Oppong R; Do Thi Thuy N; Phodha T; Celhay O; Guerin PJ; Wertheim H; Lubell Y
    Antimicrob Resist Infect Control; 2018; 7():98. PubMed ID: 30116525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The new Korean action plan for containment of antimicrobial resistance.
    Ryu S
    J Glob Antimicrob Resist; 2017 Mar; 8():70-73. PubMed ID: 28024981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility of Streptococcus suis isolated from diseased pigs, asymptomatic pigs, and human patients in Thailand.
    Yongkiettrakul S; Maneerat K; Arechanajan B; Malila Y; Srimanote P; Gottschalk M; Visessanguan W
    BMC Vet Res; 2019 Jan; 15(1):5. PubMed ID: 30606175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.